Infection by the Epstein-Barr virus between the years 2006-2015 in the health area of Santiago de Compostela. Relationship with age and sex

OBJECTIVE: In Spain, the age and sex to which the primary infection by EBV is produced is poorly studied. The objective of this work is to know its relation with the presence of the primary infection by EBV between the years 2006 and 2015 in our health area.

METHODS: From the Santiago de Compostela health area between 2006 and 2015, 578 patients with serological patterns of EBV primoinfection were selected. This patients presented serological results of IgM-VCA positive, IgG-VCA positive and EBNA negative.

RESULTS: We found 260/578 (45%) adolescents (11- 19 years). In the number of cases by age the maximum was observed, at 2 and 16 years. Between 14-19 years, 62% (79/127) of women between 14-16 years of age, median age 15.8 years (IQ: 14.8-16.4) compared to 48% (49/102) of men, median age 16 years (IQ: 15.7-16.6) (p = 0.032, p = 0.02, respectively).

CONCLUSIONS: As in our study, in the developed countries the majority of primary infections by EBV occur in adolescence and a bimodal distribution is observed in relation to age. During adolescence women acquire before men the first infection by EBV.

Medienart:

E-Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:30

Enthalten in:

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 30(2017), 6 vom: 19. Dez., Seite 468-471

Sprache:

Spanisch

Weiterer Titel:

Primoinfección por el virus Epstein-Barr entre los años 2006 a 2015 en el área sanitaria de Santiago de Compostela. Relación con edad y sexo

Beteiligte Personen:

Trastoy Pena, R [VerfasserIn]
Costa Alcalde, J J [VerfasserIn]
Rodríguez Calviño, J [VerfasserIn]
Navarro de la Cruz, D [VerfasserIn]
Barbeito Castiñeiras, G [VerfasserIn]
Aguilera Guirao, A [VerfasserIn]

Themen:

Immunoglobulin G
Immunoglobulin M
Journal Article

Anmerkungen:

Date Completed 14.08.2018

Date Revised 14.08.2018

published: Print-Electronic

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM278267912